Skip to content

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Learn more

Classification and Stages of the Disease

Visual guide showcasing classification and stages of Neuroendocrine Tumors (NET).

NET disease classification and stages

NETs, like any tumor, are ‘graded’ based on the World Health Organisation (WHO) systems: low (Grade 1/G1), intermediate (Grade 2/G2) or high (Grade 3/G3). Grade represents how advanced the tumor has grown. Grading the tumor helps doctors establish the best plan for managing a NET.2

A pathologist is a specialized doctor who determines the tumor’s grade after carefully looking at a sample of it under a microscope (known as a biopsy). To figure out the tumor grade, the pathologist takes several criteria into account. You may hear the term Ki-67 index. This is a measure of how quickly the tumor cells are growing and making new cells. Higher numbers reflect more rapidly growing tumors.

.

Pathologists also evaluate how different the tumor cells look from the normal surrounding cells. A tumor is considered “well-differentiated” if the tumor cells look like nearby healthy tissues and appear fairly organized. A tumor is considered “poorly differentiated” if the tumor cells look very different, disorganized and abnormal from the surrounding healthy tissues. Why is this information important? This helps get a clearer picture of how the tumor is behaving. Often times, poorly-differentiated tumors grow and spread faster than well-differentiated tumors, so this information is used to help guide treatment options and next steps in care.

.

Cancer stage refers to the extent of cancer, depending on how large the tumor is, as well as whether it has spread to other areas of the body (metastasized). Staging varies for different types of tumors, but most guidelines recommend a system of four stages, with stage 4 indicating metastasis or spreading to distant areas of the body.3

.

Typical signs and symptoms Emotional well-being
You’re now leaving the website myNETjourney.com
This link is provided for information purposes only. Please be aware that, if you click on it, you will leave myNETjourney.com website. The link will take you to a website owned and operated by an independent party over which ITM Oncologics GmbH has no control or influence (“third-party website”).
ITM Oncologics GmbH makes no representation that information on the third-party website is appropriate or available for use or access in locations outside the country for which the third-party website is intended. Therefore, ITM Oncologics GmbH declines any responsibility for third-party information. ITM Oncologics GmbH makes no representation regarding the data usage policies of the third party website and declines any responsibility for the use of personal data by the operator of the third-party website. Please ensure that you belong to the intended audience of the content provided on third-party website and that your access to it complies with the applicable laws and regulations.
 
Do you really want to leave the myNETjourney.com website?
Welcome to myNETjourney.com
In order to provide you with information tailored to your needs, we kindly ask you to select one of the following: